drugset
drugset / Trial / NCT05151705

A Trial of HR17031 Injection With Hepatic Insufficiency

NCT05151705 ↗

Phase 1 Unknown 24 enrolled Jiangsu HengRui Medicine Co., Ltd.
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This study used a single-dose, open design to compare the pharmacokinetics of subjects with mild and moderate liver impairment and subjects with normal liver function.

Timeline

Start
2021-12-20
Primary completion
2022-06-15
Completion
2022-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject HR17031 Unknown 0.024 mg —
Subject HR17031 Unknown 10 iu —

Indications

No indication recorded.